Science Friday

How Did Vaccine Policies Actually Change In 2025?

December 22, 2025

Key Takeaways Copied to clipboard!

  • The administration under Health Secretary Robert F. Kennedy Jr. has shifted federal vaccine policy away from universal recommendations, exemplified by the CDC ending the routine infant Hepatitis B birth dose recommendation, reverting to a pre-1991 risk-based approach. 
  • Changes to COVID-19 vaccine guidance are confusing and contradictory, leading to reduced demand and logistical issues where pediatricians may stop stocking the vaccine, making it significantly harder for parents to vaccinate infants and toddlers. 
  • A climate of suspicion fueled by the administration's stance, coupled with fears related to immigration enforcement (ICE raids), is contributing to decreased uptake at public health vaccination clinics, particularly among immigrant populations. 

Segments

Introduction and Context Setting
Copied to clipboard!
(00:00:00)
  • Key Takeaway: Federal vaccine policy has fundamentally shifted in 2025, contrasting with historical expansion since 1955.
  • Summary: The podcast sets the stage by noting that 2025 marks a departure from the federal government’s long-standing role in expanding vaccine access, citing Health Secretary Robert F. Kennedy Jr.’s administration casting doubt on vaccine safety. The episode aims to clarify the practical impact of these new stances on vaccine access and uptake one year in. Guests Arthur Allen and Jackie Fortiér from KFF Health News are introduced to analyze these changes.
Hepatitis B Vaccine Policy Change
Copied to clipboard!
(00:02:11)
  • Key Takeaway: The CDC ended the universal Hepatitis B birth dose recommendation, reverting to a risk-based approach similar to pre-1991 standards.
  • Summary: The CDC recently ended its nearly 35-year recommendation for infants to receive the Hepatitis B vaccine immediately after birth. Hepatitis B is a highly infectious virus attacking the liver with no cure, making the three-dose vaccine crucial, especially within the first 12 hours for babies born to mothers with unknown viral status. This policy change is viewed as not evidence-based and is expected to increase misinformation and parental questioning regarding the vaccine’s safety and necessity.
COVID-19 Vaccine Access Challenges
Copied to clipboard!
(00:05:29)
  • Key Takeaway: Conflicting guidance and reduced demand are causing pharmacies and pediatricians to stop stocking the COVID-19 vaccine, hindering access for young children.
  • Summary: The COVID-19 vaccine recommendations are complicated, with contradictory statements from leadership versus CDC updates, such as guidance on pregnant women. Reduced demand means some providers are choosing not to carry the vaccine due to high cost and short shelf life, leading to waste. Pharmacists cannot vaccinate babies, forcing parents seeking the multi-dose series for young children to travel significant distances to find pediatricians who still offer it.
Impact on Public Health Clinics
Copied to clipboard!
(00:09:13)
  • Key Takeaway: Back-to-school vaccination clinics are seeing half the attendance, potentially due to reduced CDC advertising and fear of immigration enforcement actions.
  • Summary: Public health departments offering routine vaccinations are observing dramatically declining attendance rates compared to the previous year. Anecdotal evidence suggests that fear surrounding ICE raids is deterring Latino and other immigrant populations from utilizing public health clinics where they previously sought vaccines. This decline is also seen in COVID-19 vaccination rates among children and vulnerable older adults, raising concerns about a more severe winter hospitalization season.
Navigating Future Vaccine Changes
Copied to clipboard!
(00:11:02)
  • Key Takeaway: Despite policy shifts, insurance is expected to cover recommended vaccines, but availability and personal effort will determine actual access.
  • Summary: The administration’s skepticism affects all communities, evidenced by ongoing measles and whooping cough outbreaks. The current approach suggests that while vaccines may not be legally removed, the decision is framed as being ‘up to you,’ meaning insurance should cover them if sought. The practical challenge lies in whether the vaccines remain readily available and accessible, especially given the increased effort required to obtain them.